Research Papers

24 of 174 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Humanizing the mdx mouse model of DMD: the long and the short of it.
Yucel N; Chang AC; Day JW; Rosenthal N; Blau HM.
NPJ Regen Med (Unknown)
Published: 2018
2/6 Transparent
Funding Declared
Erratum: Intravenous delivery of adeno-associated virus 9-encoded IGF-1Ea propeptide improves post-infarct cardiac remo…
Gallego-Colon E; Villalba M; Tonkin J; Cruz F; Bernal JA; Jimenez-Borregureo LJ; Schneider MD; Lara-Pezzi E; Rosenthal N.
NPJ Regen Med (Unknown)
Published: 2017
Erratum: Author Correction: Injection of embryonic stem cell-derived macrophages ameliorates fibrosis in a murine model…
Haideri SS; McKinnon AC; Taylor AH; Kirkwood P; Lewis PJS; O'Duibhir E; Vernay B; Forbes S; Forrester LM.
NPJ Regen Med (Unknown)
Published: 2017
Erratum: Restoring heart function and electrical integrity: Closing the circuit.
Monteiro LM; Vasques-Nóvoa F; Ferreira L; Pinto-do-Ó P; Nascimento DS.
NPJ Regen Med (Unknown)
Published: 2017
Identification of regenerative roadblocks via repeat deployment of limb regeneration in axolotls.
Bryant DM; Sousounis K; Payzin-Dogru D; Bryant S; Sandoval AGW; Martinez Fernandez J; Mariano R; Oshiro R; Wong AY; Leigh ND; Johnson K; Whited JL.
NPJ Regen Med (Unknown)
Published: 2017
3/6 Transparent
Data Funding Declared
Neuronal replacement therapy: previous achievements and challenges ahead.
Grade S; Götz M.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Preclinical imaging methods for assessing the safety and efficacy of regenerative medicine therapies.
Scarfe L; Brillant N; Kumar JD; Ali N; Alrumayh A; Amali M; Barbellion S; Jones V; Niemeijer M; Potdevin S; Roussignol G; Vaganov A; Barbaric I; Barrow M; Burton NC; Connell J; Dazzi F; Edsbagge J; French NS; Holder J; Hutchinson C; Jones DR; Kalber T; Lovatt C; Lythgoe MF; Patel S; Patrick PS; Piner J; Reinhardt J; Ricci E; Sidaway J; Stacey GN; Starkey Lewis PJ; Sullivan G; Taylor A; Wilm B; Poptani H; Murray P; Goldring CEP; Park BK.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Single-cell analysis of the fate of c-kit-positive bone marrow cells.
Czarna A; Sanada F; Matsuda A; Kim J; Signore S; Pereira JD; Sorrentino A; Kannappan R; Cannatà A; Hosoda T; Rota M; Crea F; Anversa P; Leri A.
NPJ Regen Med (Unknown)
Published: 2017
3/6 Transparent
Data Funding Declared
Translational considerations in injectable cell-based therapeutics for neurological applications: concepts, progress an…
Amer MH; Rose FRAJ; Shakesheff KM; Modo M; White LJ.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
A blueprint for the next generation of ELSI research, training, and outreach in regenerative medicine.
Illes J; Sipp D; Kleiderman E; Benjaminy S; Isasi R; Lomax G; Master Z; McCormick J; Ogbogu U; Ravitsky V; Robillard JM; Rossi F; Wilson B; Zarzeczny A.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
The adaptive immune response to cardiac injury-the true roadblock to effective regenerative therapies?
Sattler S; Fairchild P; Watt FM; Rosenthal N; Harding SE.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Translational cardiac stem cell therapy: advancing from first-generation to next-generation cell types.
Cambria E; Pasqualini FS; Wolint P; Günter J; Steiger J; Bopp A; Hoerstrup SP; Emmert MY.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Biomimetic heterogenous elastic tissue development.
Tsai KJ; Dixon S; Hale LR; Darbyshire A; Martin D; de Mel A.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Injection of embryonic stem cell derived macrophages ameliorates fibrosis in a murine model of liver injury.
Haideri SS; McKinnon AC; Taylor AH; Kirkwood P; Starkey Lewis PJ; O'Duibhir E; Vernay B; Forbes S; Forrester LM.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Restoring heart function and electrical integrity: closing the circuit.
Monteiro LM; Vasques-Nóvoa F; Ferreira L; Pinto-do-Ó P; Nascimento DS.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
The protein tyrosine phosphatase 1B inhibitor MSI-1436 stimulates regeneration of heart and multiple other tissues.
Smith AM; Maguire-Nguyen KK; Rando TA; Zasloff MA; Strange KB; Yin VP.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Regenerative medicine funding policies in Europe and The Netherlands.
de Haan G; de Crom R; Dzierzak E; Mummery C.
NPJ Regen Med (Unknown)
Published: 2017
1/6 Transparent
Cxcl14 depletion accelerates skeletal myogenesis by promoting cell cycle withdrawal.
Waldemer-Streyer RJ; Reyes-Ordoñez A; Kim D; Zhang R; Singh N; Chen J.
NPJ Regen Med (Unknown)
Published: 2017
2/6 Transparent
Funding Declared
Evolution, comparative biology and ontogeny of vertebrate heart regeneration.
Vivien CJ; Hudson JE; Porrello ER.
NPJ Regen Med (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
An acellular biologic scaffold treatment for volumetric muscle loss: results of a 13-patient cohort study.
Dziki J; Badylak S; Yabroudi M; Sicari B; Ambrosio F; Stearns K; Turner N; Wyse A; Boninger ML; Brown EHP; Rubin JP.
NPJ Regen Med (Unknown)
Published: 2016
3/6 Transparent
Registered Funding Declared
Tissue- and time-directed electroporation of CAS9 protein-gRNA complexes in vivo yields efficient multigene knockout fo…
Fei JF; Knapp D; Schuez M; Murawala P; Zou Y; Pal Singh S; Drechsel D; Tanaka EM.
NPJ Regen Med (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Intravenous delivery of adeno-associated virus 9-encoded IGF-1Ea propeptide improves post-infarct cardiac remodelling.
Gallego-Colon E; Villalba M; Tonkin J; Cruz F; Bernal JA; Jimenez-Borregureo LJ; Schneider MD; Lara-Pezzi E; Rosenthal N.
NPJ Regen Med (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy.
Dumont NA; Rudnicki MA.
NPJ Regen Med (Unknown)
Published: 2016
2/6 Transparent
Funding Declared
CRISPR/Cas9-based genetic correction for recessive dystrophic epidermolysis bullosa.
Webber BR; Osborn MJ; McElroy AN; Twaroski K; Lonetree CL; DeFeo AP; Xia L; Eide C; Lees CJ; McElmurry RT; Riddle MJ; Kim CJ; Patel DD; Blazar BR; Tolar J.
NPJ Regen Med (Unknown)
Published: 2016
2/6 Transparent
Funding Declared